CN105833148A - Traditional Chinese medicine composition with effects of improving memory, resisting arteriosclerosis, inhibiting thrombosis and improving immunity - Google Patents
Traditional Chinese medicine composition with effects of improving memory, resisting arteriosclerosis, inhibiting thrombosis and improving immunity Download PDFInfo
- Publication number
- CN105833148A CN105833148A CN201610300845.1A CN201610300845A CN105833148A CN 105833148 A CN105833148 A CN 105833148A CN 201610300845 A CN201610300845 A CN 201610300845A CN 105833148 A CN105833148 A CN 105833148A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- improving
- blood
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 171
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 230000036039 immunity Effects 0.000 title claims abstract description 25
- 206010003210 Arteriosclerosis Diseases 0.000 title claims abstract description 17
- 208000011775 arteriosclerosis disease Diseases 0.000 title claims abstract description 17
- 208000007536 Thrombosis Diseases 0.000 title claims abstract description 15
- 230000000694 effects Effects 0.000 title abstract description 45
- 230000002401 inhibitory effect Effects 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 claims abstract description 48
- 239000008280 blood Substances 0.000 claims abstract description 48
- 235000000346 sugar Nutrition 0.000 claims abstract description 15
- 238000009835 boiling Methods 0.000 claims description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 210000000582 semen Anatomy 0.000 claims description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 32
- 201000010099 disease Diseases 0.000 claims description 31
- 239000000706 filtrate Substances 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 24
- 235000014101 wine Nutrition 0.000 claims description 23
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 22
- 239000002994 raw material Substances 0.000 claims description 21
- 230000036541 health Effects 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 17
- 238000002386 leaching Methods 0.000 claims description 14
- 230000009471 action Effects 0.000 claims description 12
- 206010010774 Constipation Diseases 0.000 claims description 10
- 230000003064 anti-oxidating effect Effects 0.000 claims description 9
- 230000005764 inhibitory process Effects 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 8
- 210000002307 prostate Anatomy 0.000 claims description 6
- 230000001093 anti-cancer Effects 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000003390 Chinese drug Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 230000001976 improved effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 208000026455 prostate symptom Diseases 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 28
- 210000003734 kidney Anatomy 0.000 description 22
- 239000007788 liquid Substances 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 230000006870 function Effects 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 15
- 238000009826 distribution Methods 0.000 description 10
- 230000002708 enhancing effect Effects 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 230000000144 pharmacologic effect Effects 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 9
- 230000001629 suppression Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 102000007330 LDL Lipoproteins Human genes 0.000 description 7
- 108010007622 LDL Lipoproteins Proteins 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- -1 hydroxypropyl Chemical class 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 235000014510 cooky Nutrition 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000001647 Renal Insufficiency Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229960001031 glucose Drugs 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229960001375 lactose Drugs 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000209051 Saccharum Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000002790 anti-mutagenic effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N hydroxymethyl benzene Natural products OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 229960003194 meglumine Drugs 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000004223 radioprotective effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 241000572565 Alpinia oxyphylla Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000025494 Aortic disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 241000269417 Bufo Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 206010065873 Pulmonary fistula Diseases 0.000 description 1
- 244000173166 Pyrus ussuriensis Species 0.000 description 1
- 235000011572 Pyrus ussuriensis Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- JHJUUEHSAZXEEO-UHFFFAOYSA-M sodium;4-dodecylbenzenesulfonate Chemical group [Na+].CCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 JHJUUEHSAZXEEO-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition with the effects of improving memory, resisting arteriosclerosis, inhibiting thrombosis and improving immunity. The traditional Chinese medicine composition is prepared from, by weight, 3-6 parts of fructus alpiniae oxyphyllae, 9-15 parts of poria cocos, 10-30 parts of rhizoma polygonati and 5-10 parts of barbary wolfberry fruit. The traditional Chinese medicine composition has the effects of improving the memory, resisting the arteriosclerosis, inhibiting the thrombosis, improving the immunity, improving prostate symptoms, resisting fatigue, improving sleep, reducing blood fat and blood sugar level, resisting oxidation and cancers, beautifying the features, facilitating feces excretion, losing weight and the like.
Description
Technical field
The present invention relates to Chinese medicine composition, specifically, relate to one and improve memory, resist and move
Arteries and veins hardening, inhibition thrombosis, the integration of edible and medicinal herbs compositions of raising immunity.
Background technology
With regard to people all one's life for, functional activity experiencings evolution." Ling Shu Miraculous Pivot or Divine Axis natural life-span " is called:
" life ten years old, it is fixed that the five internal organs begin, and vim and vigour are the most logical, its gas under, therefore convenient for walking.20 years old, blood
Gas begins to contain, muscle side head, therefore becomes well.30 years old, the five internal organs were the most fixed, and muscle is firm, and blood vessels are contained
Full, therefore good step.40 years old, the vital organs of the human body twelve regular channels, the biggest Sheng is to calm down, and space between skin and muscles begins to dredge,
High honour ruined fall, send out frequency the most grizzled, flat Sheng is not shaken, therefore good sits.50 years old, irritability began to decline, lobe of the liver
Beginning thin, bile begins to go out, and mesh begins not clear.Threescore, the motive begins to decline, and bitter melancholy is sad, and vim and vigour are slack lazy,
Therefore it is good sleeping.70 years old, deficiency of spleen-QI, skin was withered.80 years old, lung qi declined, soul from, therefore speech is kind
By mistake.90 years old, kidney qi was burnt, and four dirty passages through which vital energy circulates are hollow.At the age of one hundred years old, the five internal organs are the most empty, and manner is all gone,
Human skeleton solitary and eventually.”
Knowable to life track at the age of one hundred years old, body is being struggled against with paathogenic factor always, and disease is originally
Body is also at development change, has multiple different development and change stage.These are interim
Showing, disease is omnidistance, and card is the stage.Demonstrate,prove than simple symptom or name of disease more can comprehensively,
Deeply, the essence of disease change is disclosed definitely.Treating the same disease with different methods or different is there is again between disease and card
The relation that disease is ruled together, so health preserving to be paid attention to demonstrate,proving different disease, different card is with sick, or treating the same disease with different methods,
The relation for the treatment of different diseases with the same therapeutic principle.Deficiency of the kidney yin to be prevented and treated, insufficiency of kidney-YANG, kidney insufficiency, the hepatic and renal YIN deficiency,
The card such as deficiency of spleen-YANG and kidneyYANG, deficiency of heart-yin, deficiency of heart-YANG, depression of liver-QI, disarmony between the heart and kidney, the lung qi deficiency of YIN
Occur.These cards disclose the deficient of internal organs.So must prevent and treat for these tens kinds of diseases.
Huangdi's Internal Classics proposed the "prevention first" prevented trouble before it happens before more than 2,000 years,
Think that the tidemark of medical science is " sage's preventing diseases instead for the treatment of diseases is not controlled and disorderly controlled disorderly " (" element
Ask regulating life activities according to natural changes in four seasons big opinion ").To the Tang Dynasty, Sun Simiao propose " disease of upper doctor doctor's not disease, in
Doctor doctor is intended to the disease of disease, the disease of lower doctor doctor's disease " (" preemergency a thousand pieces of gold prescription volume 27 ", by disease
Disease is divided into " not sick ", " being intended to disease ", " sick " three levels, it is believed that upper doctor is maintaining healthy
Medicine of keeping good health, the traditional Chinese medical science is the preventive medicine of early intervention, and lower doctor is the treatment medical science for disease.
Under method for the treatment of instructs, experience accumulation in thousands of years, existing for the prescription preventing and treating a large amount of diseases
About thousand is first, but Chinese medicine is divided into the Chinese medicine of broad sense according to R&D of modern TCM, can be used for keeping healthy
The Chinese medicine of product, medicinal and edible Chinese medicine.The health preserving of medicinal and edible Chinese medicine upper doctor preventive treatment of disease is first
Choosing.And in existing about thousand first prescriptions, Fang Zhongquan is that the formula proportion of medicinal and edible Chinese medicine is little,
And prevent and treat common several of present majority with the formula and can relate to being full medicinal and edible Chinese medicine composition
Ten kinds of sick prescriptions are the most few.
Never sick is to gradually form to severe disease, and the most long-term process, it is right that present people recognizes
Main sick kind that human life and function harm highlight is: hypomnesis (dull-witted), tremulous pulse are hard
The diseases such as change, various thrombosis.
Accordingly, it would be desirable to develop one employing can prevent and treat harmful to human life and function disease, again
The Chinese medicine composition of the health care of the medicinal and edible Chinese medicine that the suitable people of energy take everyday.
Summary of the invention
In order to overcome the deficiencies in the prior art, the goal of the invention of the present invention is to provide one to have
Improve the integration of edible and medicinal herbs group of memory, arteriosclerosis, inhibition thrombosis, raising immunity
Compound.
Another goal of the invention of the present invention is to provide the preparation side of this medicinal and edible Chinese medicine compositions
Method.
An also goal of the invention of the present invention is to provide the health preserving of this medicinal and edible Chinese medicine compositions
Wine.
An also goal of the invention of the present invention is that the health preserving providing this medicinal and edible Chinese medicine compositions is drunk
Material, food etc..
Another goal of the invention of the present invention is to provide the application of this medicinal and edible Chinese medicine compositions.
In order to realize the object of the invention, the present invention provide one improve memory, arteriosclerosis,
Inhibition thrombosis, the Chinese medicine composition of raising immunity, it is characterised in that described Chinese drug-treated group
Compound comprises the Chinese medicine of following weight portion: Fructus Alpiniae Oxyphyllae 3-6 part, Poria 9-15 part, Rhizoma Polygonati 10-30
Part, Fructus Lycii 5-10 part.
In above-mentioned Chinese medicine composition:
Described weight portion can be unit of weight known to the field of medicaments such as μ g, mg, g, kg, also
Can be its multiple, such as 1/10,1/100,10 times, 100 times etc..
These, it is preferred to, Fructus Alpiniae Oxyphyllae 4-6 part, Poria 12-15 part, Rhizoma Polygonati 20-30 part, Chinese holly
Fructus Lycii 5-10 part.
Further, Chinese medicine composition of the present invention also includes 5-9 part Folium Mori, preferably 6-9 part Folium Mori.
Further, Chinese medicine composition of the present invention also includes 10-30 part Fructus Jujubae, preferably 10-20
Part Fructus Jujubae.
Chinese medicine composition of the present invention can also add Radix Angelicae Sinensis in right amount, and Radix Angelicae Sinensis consumption is 5-15 part, preferably
For 8-15 part.
Present invention also offers the preparation method of above-mentioned Chinese medicine composition, it comprises the following steps:
Weighing each Chinese medicine ingredients according to proportioning, be then soaked in water 30-60 minute by Chinese medicine, amount of water is
5-6 times of Chinese medicine gross weight, then boils, and after boiling, little fire boiling state, decocts 1-2 hour, cross leaching
Filtrate, adds the water of Chinese medicine gross weight 5-6 times, decocts 1 hour, filters, merges twice filtrate,
Concentrate, to obtain final product.
Containing the health preserving wine of above-mentioned Chinese medicine composition, it uses following steps to make: according to proportioning
Weighing each Chinese medicine ingredients, be then soaked in water 30-60 minute by Chinese medicine, amount of water is Chinese medicine gross weight
5-6 times of amount, then boils, and after boiling, little fire boiling state, decocts 1-2 hour, cross leaching filtrate, then
Add the water of Chinese medicine gross weight 5-6 times, decoct 1 hour, filter, merge twice filtrate, be concentrated into
Be equivalent to 1-2 times of crude drug weight, obtain Chinese medicine composition decoction, then Chinese medicine composition decoction
Blending with wine, the volume ratio of Chinese medicine composition decoction and this wine is 1:(1-5), health preserving wine.
Can also blend and obtain concentration in a series of difference, the Chinese medicament healthcare wine of different alcohol concentration.
Described wine is high quality liquor, rice wine, wine, yellow wine, red wine etc., wherein with high-quality
Chinese liquor is preferred, especially with aromatic Chinese spirit more preferably.Its number of degrees are less than or equal to 60 degree, as 53 degree,
42 degree, 38 degree etc..
The present invention containing above-mentioned Chinese medicine composition preparation can separately made by this Chinese medicine composition or by
This Chinese medicine composition and pharmaceutically acceptable carrier composition.
Described preparation is decoction, tablet, capsule, pill or oral liquid.Described pharmaceutically may be used
The carrier accepted refers to the pharmaceutical carrier that pharmaceutical field is conventional, selected from filler, binding agent, collapses
Solve agent, lubricant, solubilizing agent, suspending agent, wetting agent, pigment, essence, solvent, surface
One or more in activating agent or correctives.
Described filler selected from starch, pregelatinized Starch, dextrin, glucose, sucrose, lactose,
Lactose, microcrystalline Cellulose, mannitol, sorbitol or xylitol, preferably sorbitol, crystallite
Cellulose, lactose or pregelatinized Starch.
Described disintegrating agent is selected from cross-linking sodium carboxymethyl cellulose, polyvinylpolypyrrolidone, low-substituted hydroxypropyl
Base cellulose, carboxymethyl starch sodium or starch, preferably polyvinylpolypyrrolidone, low substituted hydroxy-propyl fibre
Dimension element or carboxymethyl starch sodium.
Described lubricant selected from magnesium stearate, Pulvis Talci, micropowder silica gel, PEG4000, PEG6000,
Sodium laurylsulfate, preferably magnesium stearate, Pulvis Talci.
Described binding agent selected from sodium carboxymethyl cellulose, hydroxypropyl methylcellulose, ethyl cellulose,
Polyvidone, starch slurry, sucrose, Icing Sugar, rubber cement, gelatin, Polyethylene Glycol, preferably hydroxypropyl first
Base cellulose, polyvidone.
Described solubilizing agent relies selected from sodium hydroxide, potassium hydroxide, sodium bicarbonate, meglumine, L-
Propylhomoserin, L-arginine, preferably sodium hydroxide, meglumine.
Described suspending agent is selected from micropowder silica gel, Cera Flava, cellulose, solid polyethylene glycol.
Described wetting agent is selected from glycerol, tween 80, ethoxy aluminium Oleum Ricini or lecithin.
Described solvent selected from ethanol, liquid polyethylene glycol, isopropanol, tween 80, glycerol, third
Glycol or vegetable oil, described vegetable oil is selected from soybean oil, Oleum Ricini, Oleum Arachidis hypogaeae semen, mixed oil etc..
Described surfactant is selected from dodecylbenzene sodium sulfonate, stearic acid, polyoxyethylene-polyoxy
Propylene copolymer, fatty acid Pyrusussuriensis be smooth or Polysorbate (tween) etc..
Described correctives is selected from aspartame, Sucralose, essence, steviosin, acesulfame potassium, lemon
Lemon acid or saccharin sodium.
It is also possible to the present invention is made various beverage or food containing above-mentioned Chinese medicine composition,
It is easy to carry, instant.
For during as beverage or food, Chinese medicine composition of the present invention can further include
10-30 part Semen Sesami Nigrum, 9-30 part Semen Coicis, preferably 15-30 part Semen Sesami Nigrum, 15-30 part Semen Coicis.
When preparing food, can first use and Semen Sesami Nigrum and Semen Coicis are crushed to 100-200 jointly
Mesh, then mix, finally according to food preparation processes with other raw material of Chinese medicine decocting in water extracting solution
Make, the dessert of such as all styles of, cookies etc..
Certainly, when for food processing, Poria can also divide two parts to add, a part of Fu
Siberian cocklebur can be pulverized and mixed together with Semen Sesami Nigrum, Semen Coicis and join in food.
Wherein, Semen Sesami Nigrum is preferred to fry with Semen Coicis.
Present invention also offers above-mentioned Chinese medicine composition at preparation treatment or preventing and treating body subhealthy status
Application in disease product.Application is specifically related to improve memory, arteriosclerosis, suppression blood
Bolt formed, improve immunity, improve prostate gland symptoms, resisting fatigue, improvement sleep, blood fat reducing,
Blood sugar lowering, and the aspect such as antioxidation, anticancer, beauty treatment, relieving constipation, fat-reducing.
Chinese medicine composition of the present invention can be also used for prevent and treat deficiency of the kidney yin, insufficiency of kidney-YANG, kidney insufficiency,
The hepatic and renal YIN deficiency, deficiency of spleen-YANG and kidneyYANG, deficiency of heart-yin, deficiency of heart-YANG, depression of liver-QI, disarmony between the heart and kidney etc. nine are demonstrate,proved
With lung heat clearing, moisturize.
The primary efficacy of the Chinese medicine composition of medicine-food two-purpose used by the present invention, meridian distribution of property and flavor, function
Cure mainly, compatibility potentiation, pharmacological action are discussed below respectively:
Fructus Alpiniae Oxyphyllae:
Meridian distribution of property and flavor: pungent, temperature.Return kidney, spleen channel.
Function cures mainly: warming the kidney to invigorate YANG, controlling nocturnal emission with astringent drugs reducing urination, warming spleen and stopping diarrha, takes the photograph saliva and stops saliva.Main use
In insufficiency of kidney-YANG, frequent urination and enuresis, emission and spermatorrhea, middle Jiao is cold, the cold pain of gastral cavity abdomen, vomiting and diarrhoea lack of appetite,
Mouth saliva gravity flow.
Pharmacological action: the activity of left atrium contracts power can be strengthened, there is cardiotonic.To reproduction
The impact of system, Fructus Alpinae Oxyphyllae extract can suppress the activity of prostaglandin synthetase.Have anticancer,
Defying age, improve the effect of memory.
Primary healthcare effect: have and improve the effect such as memory, antioxidation.
Poria:
Meridian distribution of property and flavor: sweet, light, flat.GUIXIN, spleen, kidney channel.
Function cures mainly: inducing diuresis to remove edema, eliminating dampness by diuresis, spleen invigorating, mind calming.Be mainly used in edema, phlegm retention,
Diarrhea due to hypofunction of the spleen, cardiopalmus, insomnia etc..
Pharmacological action: make the third paddy aminotransferase activity substantially reduce, prevent hepatic necrosis.Strengthen
Myocardial contraction, has obvious diuresis, improves immunity, blood sugar lowering, antitumor, promotes
Hemopoietic.
Primary healthcare effect: have enhancing immunity, blood sugar lowering, blood fat reducing, the liver protecting,
Improve memory, improve the effect such as anoxia endurance, antitumor.
Rhizoma Polygonati:
Meridian distribution of property and flavor: sweet, puts down, returns spleen, lung, kidney.
Function cures mainly: lung moistening YIN nourishing, invigorating the spleen and replenishing QI.Being mainly used in deficiency of the lung cough caused by dryness, consumptive disease is coughed hemoptysis,
Blood and essence asthenia, interior-heat quenches one's thirst, insufficiency of the spleen asthenia, and xerostomia lack of appetite is hard and dry.
Pharmacological action: to blood fat and the effect of arteriosclerosis: Rhizoma Polygonati decocting liquid and ethanol extraction
Serum cholesterol and glycerol three acid content can be significantly reduced, the speckle on aorta wall film can be made to subtract
Few and Coronary Artery Atherosclerosis alleviates.There is hypoglycemic activity, there is antioxidation, carry
The ability of high body free radical resisting, enhancing immunity etc. acts on.
Primary healthcare effect: there is blood fat reducing, blood sugar lowering, enhancing immunity, antioxidation, delay
Physical fatigue, the liver protecting etc. acts on.
Fructus Lycii:
Meridian distribution of property and flavor: sweet is flat.Return liver, kidney channel.
Function cures mainly: the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, nourishing the lung to arrest cough.It is mainly used in lumbago due to renal deficiency,
Emission and spermatorrhea, sexual impotence, long fertility, interior-heat quenches one's thirst, blood deficiency and yellow complexion, poor vision, dizzy
Dizzy, deficiency of YIN phthisical cough, middle dizziness due to wind, fidgets due to deficiency insomnia, rheumatic arthralgia etc..
Pharmacological action: have blood sugar lowering, blood fat reducing and protect the liver, lipotropy；Have anti-
Function of tumor；There is resisting fatigue；Radioprotective；Anoxia enduring；Blood pressure lowering；Mutation；Antioxygen is turned into
With.
Primary healthcare effect: there is enhancing immunity, alleviating physical fatigue, antioxidation, alleviation
Asthenopia, the liver protecting etc. act on.
Radix Angelicae Sinensis:
Meridian distribution of property and flavor: sweet, pungent, temperature.Return liver, the heart, spleen channel.
Function cures mainly: replenishing and activating blood, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Cure mainly blood deficiency and yellow complexion, the moon
Through uncomfortable, amenorrhea dysmenorrhea, blood deficiency, stasis, all pains of cold in blood, traumatic injury, rheumatic arthralgia,
Ulcer sores, dryness of the intestine constipation etc..
Pharmacological action: the impact on cardiovascular system: Radix Angelicae Sinensis has blood fat reducing, hard to aorta
Change, aortic disease has certain protective role.Ligustilide from Angelica sinensis has suppression platelet aggregation
Effect.Radix Angelicae Sinensis and ferulic acid thereof have obvious anti thrombotic action.Radix Angelicae Sinensis polysaccharide has promotion and makes
The effect of blood function, increases the effect of coronary flow, has enhancing immunity function.Also have
Protect the liver, antitumor, radioprotective, antiinflammatory, antioxidation, the effect such as correction protein metabolism disorder.
Primary healthcare effect: have enhancing immunity, the liver protecting, promotes hemopoietic, expansion hat
Shape tremulous pulse and peripheral blood vessel.Suppression platelet aggregation, arrhythmia etc. acts on.
Fructus Jujubae:
Meridian distribution of property and flavor: sweet, temperature.Return spleen, stomach warp.
Function cures mainly: invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind, relaxes the property of medicine.It is mainly used in weakness of the spleen and stomach,
Anorexia and loose stool, blood deficiency and yellow complexion, palpitation and insomnia, women is dirty dry, irritability etc..
Pharmacological action: hypotensive effect: benzyl alcohol glycoside in Fructus Jujubae, naringenin (multipleization such as glucosides
Compound) there is notable hypotensive effect.Antimutagenic effect: Fructus Jujubae decocting liquid has antimutagenic effect.
In addition Fructus Jujubae still has certain antitumor, resisting I-type allergic reaction, resisting fatigue, the effect such as protects the liver.
Primary healthcare effect: there is enhancing immunity, alleviating physical fatigue, improvement sleep, protect
Hepatoprotective is dirty, improve the effects such as nutritional anemia.
Folium Mori:
Meridian distribution of property and flavor: sweet, bitter, cold.Return lung, Liver Channel.
Function cures mainly: dispelling wind and heat pathogens, clearing away lung-heat and moistening for dryness, suppressing liver-YANG, liver heat removing and eyesight improving, and removing heat from blood is only
Blood.Be mainly used in anemopyretic cold, epidemic febrile disease from the beginning of, cough due to lung-heat, cough caused by dryness-heat, excessive rising of liver-YANG,
Conjunctival congestion is dim-sighted, and heat in blood coughs cards such as telling epistaxis.
Pharmacological action: hypoglycemic activity: Folium Mori total polysaccharides has significant hypoglycemic activity, and can
Improve the resistance to sugar ability of diabetic mice, increase liver glycogen content and reduce hepatic glucose, improve
Insulin level in normal rat blood.Additionally, its blood sugar lowering mechanism is also risen by some inorganic elementss
Certain effect.Impact on vascular system: rutin, Quercetin contained in Folium Mori can increase
The contractility of the in vitro and in place frog heart and cardiac output, and decreased heart rate.Rutin makes under Bufo siccus
Limb and rabbit ear vasoconstriction；The expansible coronary vasodilator of Quercetin.Rutin and Quercetin can keep
The normal resistance of blood capillary, reduces vascular permeability, can make because fragility increases hemorrhage
Blood capillary recovers normal elastic.Rutin and Cortex querci dentatae have certain hypotensive effect.
Primary healthcare effect: having blood sugar lowering, enhancing immunity, relieving constipation, functions of removing chloasma etc. is made
With.
Semen Sesami Nigrum:
Meridian distribution of property and flavor: sweet is flat.Return liver, kidney, large intestine channel.
Function cures mainly: tonification essence and blood, moisturizes laxation.It is mainly used in early whitening of beard and hair, dizziness and blurred vision,
Women's breast in puerperal is few, migratory arthralgia, and blood deficiency Tianjin is withered, dryness of the intestine constipation etc..Doctor trained in Western medicine examine into neurasthenia,
Hypertension, habitual constipation etc., belong to deficiency of the liver and kindey, blood and essence asthenia person.
Pharmacological action: anti-aging effects: Semen Sesami Nigrum can make aging phenomenon postpone occur, liver and
In testis, lipofuscin level reduces, and in blood plasma, content of vitamin E increases.The effect of cholesterol reducing:
Contained linoleic acid can reduce blood middle cholesterol content.
Primary healthcare effect: there is the effects such as blood sugar lowering, blood fat reducing, loosening bowel to relieve constipation.
Semen Coicis:
Meridian distribution of property and flavor: sweet, light, cool.Return spleen, stomach, lung meridian.
Function cures mainly: inducing diuresis to remove edema, eliminating dampness by diuresis, spleen invigorating, eliminating impediment, clearing away heat and discharging pus.It is mainly used in
Edema, dysuria, tinea pedis, diarrhea due to hypofunction of the spleen, arthralgia chiefly caused by damp pathogen contracture, pulmonary fistula, lung abscess, acute appendicitis,
Stranguria with turbid discharge, leucorrhea etc..
Pharmacological action: the effect to central nervous system: Semen Coicis has calmness, analgesic activity.
Antitumaous effect: Semen Coicis ethanol extract lumbar injection has suppression, energy to mice ehrlich carcinoma
It is obviously prolonged the existence effect of animal.
In addition Semen Coicis also induce ovulation, lower the temperature with fall heat, suppression trypsin, antibacterial,
Suppression multisynaptic reflex, blood sugar lowering, fall blood calcium, the effect of enhancing immunologic function.
Primary healthcare effect: there is the effects such as enhancing immunity, blood sugar lowering, functions of removing chloasma.
The present invention improves immunity, arteriosclerosis, inhibition thrombosis, improves memory
Integration of edible and medicinal herbs compositions, has the advantages that
Based on Chinese medicine composition the most of the present invention chooses medicinal and edible Chinese medicine raw material, grind through overtesting
Study carefully, it is determined that with the Fructus Alpiniae Oxyphyllae of specific consumption, Poria, Rhizoma Polygonati, Fructus Lycii for compatibility basis,
Reach the function of collaborative compatibility potentiation, obtain and improve immunity, arteriosclerosis, suppression thrombosis
Form, improve effect of memory；Assist a ruler in governing a country addition Folium Mori, Fructus Jujubae, Radix Angelicae Sinensis simultaneously and further,
And Semen Sesami Nigrum and Semen Coicis, can promote or widen effect of compositions further.
Chinese medicine composition the most of the present invention can be used for prevent and treat deficiency of the kidney yin, insufficiency of kidney-YANG, kidney insufficiency,
The hepatic and renal YIN deficiency, deficiency of spleen-YANG and kidneyYANG, deficiency of heart-yin, deficiency of heart-YANG, depression of liver-QI, disarmony between the heart and kidney etc. nine are demonstrate,proved
With lung heat clearing, moisturize.
Medicinal and edible Chinese medicine compositions the most of the present invention all returns kidney channel, has the kidney invigorating effect.
4. the Chinese medicine composition of the present invention has supplementing the brain benefit marrow effect, can improve brain function.
5. ACTH adrenocorticotropin (swashing) element reaction is reduced by old atrophy of adrenal gland, urine
Middle ketone corticosteroid discharge capacity is lower than between twenty and fifty, and hypoendocrinism is one of old and feeble reason.
Kidney storing essence, the raw marrow of essence, brain being the marrow sea.Therefore kidney essense fills Sheng, then brains are sufficient and limbs action spirit
Living, knowledge is clever and quick, and so-called " excess of marrow-reservoir, then light strength is strong " essence is full of marrow and fills, then brain is from strong,
The strong wisdom of then giving birth to of brain, strong will, profit knowledge, make light of one's life by commiting suicide and prolong life.Therefore prevent and treat alzheimer disease many from
Kidney tonifying marrow facilitating is started with, and otherwise loses intelligence, then dull-witted.
Chinese medicine composition the most of the present invention has and improves memory, arteriosclerosis, suppression thrombosis shape
Become, improve immunity, improve prostate gland symptoms, resisting fatigue, improvement sleep, blood fat reducing, fall
Blood glucose, and the aspect effect such as antioxidation, anticancer, beauty treatment, relieving constipation, fat-reducing.
Detailed description of the invention
Following example are used for illustrating the present invention, but are not limited to the scope of the present invention.
Embodiment 1: Chinese medicine composition decoction
1, composition: Fructus Alpiniae Oxyphyllae 40g, Poria 150g, Rhizoma Polygonati 250g, Fructus Lycii 100g, when
Return 100g, Fructus Jujubae 200g (adding up to 840g).
2, preparation method: weigh each Chinese medicine ingredients according to proportioning, is then soaked in water 40 by Chinese medicine
Minute, amount of water is 6 times (i.e. 5040g) of Chinese medicine gross weight, then boils, little fire boiling after boiling
State, decocts 2 hours, crosses leaching filtrate, adds the water (i.e. 5040g) of Chinese medicine gross weight 6 times,
After boiling, little fire boiling state, decocts 1 hour, filters, merge twice filtrate, be evaporated to 840ml,
Obtain Chinese medicine composition decoction (every ml 1g Han crude drug).
Embodiment 2: Chinese medicine composition decoction
1, composition: Fructus Alpiniae Oxyphyllae 50g, Poria 100g, Rhizoma Polygonati 200g, Fructus Lycii 80g, Radix Angelicae Sinensis
120g, Fructus Jujubae 250g (add up to 800g).
2, preparation method: weigh each Chinese medicine ingredients according to proportioning, is then soaked in water 40 by Chinese medicine
Minute, amount of water is 5 times (i.e. 4000g) of Chinese medicine gross weight, then boils, little fire boiling after boiling
State, decocts 2 hours, crosses leaching filtrate, adds the water (i.e. 4000g) of Chinese medicine gross weight 5 times,
After boiling, little fire boiling state, decocts 1 hour, filters, merge twice filtrate, be evaporated to 1600ml,
Obtain Chinese medicine composition decoction (every ml 0.5g Han crude drug).
Embodiment 3: Chinese medicine composition decoction
1, composition: Fructus Alpiniae Oxyphyllae 60g, Poria 120g, Rhizoma Polygonati 150g, Fructus Lycii 60g (add up to
390g)。
2, preparation method: weigh each Chinese medicine ingredients according to proportioning, is then soaked in water 40 by Chinese medicine
Minute, amount of water is 5 times (i.e. 1950g) of Chinese medicine gross weight, then boils, little fire boiling after boiling
State, decocts 2 hours, crosses leaching filtrate, adds the water (i.e. 1950g) of Chinese medicine gross weight 5 times,
After boiling, little fire boiling state, decocts 1 hour, filters, merge twice filtrate, be evaporated to 700ml,
Obtain Chinese medicine composition decoction (every ml 0.55g Han crude drug).
Embodiment 4: Chinese medicine composition decoction
1, composition: Fructus Alpiniae Oxyphyllae 30g, Poria 100g, Rhizoma Polygonati 250g, Fructus Lycii 100g, Mulberry
Leaf 100g (adds up to 580g).
2, preparation method: weigh each Chinese medicine ingredients according to proportioning, is then soaked in water 40 by Chinese medicine
Minute, amount of water is 5 times (i.e. 2900g) of Chinese medicine gross weight, then boils, little fire boiling after boiling
State, decocts 2 hours, crosses leaching filtrate, adds the water (i.e. 2900g) of Chinese medicine gross weight 5 times,
After boiling, little fire boiling state, decocts 1 hour, filters, merge twice filtrate, be evaporated to 600ml,
Obtain Chinese medicine composition decoction (every ml 0.96g Han crude drug).
Embodiment 5: prepared by health preserving medicated wine
1, composition: Fructus Alpiniae Oxyphyllae 60g, Poria 90g, Rhizoma Polygonati 150g, Fructus Lycii 60g, Radix Angelicae Sinensis
80g, Fructus Jujubae 150g, Folium Mori 60g (add up to 650g).
2, preparation method:
Weigh each Chinese medicine ingredients according to proportioning, then Chinese medicine is soaked in water 40 minutes, amount of water
For 5 times of Chinese medicine gross weight, then boiling, after boiling, little fire boiling state, decocts 2 hours, crosses leaching
Filtrate, adds the water of Chinese medicine gross weight 6 times, and after boiling, little fire boiling state, decocts 1 hour, filter,
Merging twice filtrate, be evaporated to 1300ml, (every ml is containing raw to obtain Chinese medicine composition decoction
Medicine 0.50g).
By Chinese medicine composition decoction and 53 degree of Chinese liquor, Chinese medicine composition volume and this Chinese liquor volume it
Ratio can be 1:1, health preserving wine, every ml crude drug Han 0.25g.
Embodiment 6: prepared by health preserving medicated wine
1, composition: Fructus Alpiniae Oxyphyllae 30g, Poria 150g, Rhizoma Polygonati 220g, Fructus Lycii 100g, when
Return 100g, Fructus Jujubae 220g (adding up to 820g).
2, preparation method:
Chinese medicine composition decoction is prepared according to the method for embodiment 2.
Chinese medicine composition decoction and 39 degree of aromatic Chinese spirits are blent, Chinese medicine composition volume with should
The ratio of Chinese liquor volume can be 1:1, health preserving wine, every ml crude drug Han 0.25g.
Embodiment 7: prepared by health preserving medicated wine
1, composition: Fructus Alpiniae Oxyphyllae 40g, Poria 120g, Rhizoma Polygonati 250g, Fructus Lycii 80g, Folium Mori
90g, Fructus Jujubae 200g (add up to 780g).
2, preparation method:
Chinese medicine composition decoction is prepared according to the method for embodiment 2.
Chinese medicine composition decoction and 39 degree of aromatic Chinese spirits are blent, Chinese medicine composition volume with should
The ratio of Chinese liquor volume can be 1:1, health preserving wine, every ml crude drug Han 0.25g.
Embodiment 8: tablet (following dosage is 10 doses of consumptions)
1, composition: Fructus Alpiniae Oxyphyllae 50g, Poria 150g, Rhizoma Polygonati 250g, Fructus Lycii 100g, when
Return 100g, Fructus Jujubae 200g, Folium Mori 80g (adding up to 920g).
2, preparation method: above-mentioned Chinese medicine is soaked 30 minutes, the water surface is higher than raw material Chinese medicine,
Amount of water is 6 times of total dose, and after boiling, little fire boiling state, maintains liquid level to be higher than raw material Chinese medicine height,
Decoct two hours, cross leaching filtrate, add the water of total dose 5 times, little fire boiling state, dimension after boiling
Hold liquid level and be higher than raw material Chinese medicine height, decoct two hours, filter and merge twice filtrate, through subtracting
Pressure concentrates (pressure 0.06MPa, temperature 65 DEG C) extremely dry cream, pulverizes, obtains 230g Chinese medicine composition
Thing (yield is 25%, every g 4g Han crude drug).
3, tablet: 100g Chinese medicine composition mixes with 50g starch, crosses 60 mesh sieves, pelletizes, dry
Dry, then add 4g magnesium stearate, tabletting, obtain tablet.
Embodiment 9: capsule
1, composition: Fructus Alpiniae Oxyphyllae 40g, Poria 100g, Rhizoma Polygonati 300g, Fructus Lycii 50g, Radix Angelicae Sinensis
80g, Fructus Jujubae 150g, Folium Mori 50g (add up to 770g).
2, preparation method: above-mentioned Chinese medicine is soaked 50 minutes, the water surface is higher than raw material Chinese medicine,
Amount of water is 5 times of total dose, and after boiling, little fire boiling state, maintains liquid level to be higher than raw material Chinese medicine height,
Decoct two hours, cross leaching filtrate, add the water of total dose 5 times, little fire boiling state, dimension after boiling
Hold liquid level and be higher than raw material Chinese medicine height, decoct two hours, filter and merge twice filtrate, through subtracting
Pressure concentrates (pressure 0.06MPa, temperature 65 DEG C) extremely dry cream, pulverizes, obtains 200.2g Chinese drug-treated group
Compound (yield is 26%, every g 3.85g Han crude drug).
3, capsule: Chinese medicine composition crosses 300 mesh sieves, weighs Chinese medicine composition 100g, adds total
The magnesium stearate of weight 2%, is distributed into capsule,.
Embodiment 10: pill
1, composition: Fructus Alpiniae Oxyphyllae 60g, Poria 150g, Rhizoma Polygonati 250g, Fructus Lycii 80g, Radix Angelicae Sinensis
100g, Fructus Jujubae 100g, Semen Sesami Nigrum 200g, Semen Coicis 100g (add up to 1040g).
2, preparation method: above-mentioned Chinese medicine is soaked 60 minutes, the water surface is higher than raw material Chinese medicine,
Amount of water is 8 times of total dose, and after boiling, little fire boiling state, maintains liquid level to be higher than raw material Chinese medicine height,
Decoct two hours, cross leaching filtrate, add the water of total dose 6 times, little fire boiling state, dimension after boiling
Hold liquid level and be higher than raw material Chinese medicine height, decoct two hours, filter and merge twice filtrate, through subtracting
Pressure concentrates (pressure 0.06MPa, temperature 65 DEG C) to dry cream.
3, pill: water is general for ball, coating,.
Embodiment 11: oral liquid
1, composition: Fructus Alpiniae Oxyphyllae 40g, Poria 125g, Rhizoma Polygonati 240g, Fructus Lycii 100g, when
Return 80g, Fructus Jujubae 250g, Folium Mori 90g (adding up to 925g).
2, preparation method: above-mentioned Chinese medicine is soaked 45 minutes, the water surface is higher than raw material Chinese medicine,
Amount of water is 8 times of total dose, and after boiling, little fire boiling state, maintains liquid level to be higher than raw material Chinese medicine height,
Decoct two hours, cross leaching filtrate, add the water of total dose 6 times, little fire boiling state, dimension after boiling
Hold liquid level and be higher than raw material Chinese medicine height, decoct two hours, filter merging filtrate, be concentrated into relatively
Density is the clear paste of 1.17 (70 DEG C), and (yield is 28%, every g to obtain 259g Chinese medicine composition
Containing crude drug 3.57g).
3, oral liquid: Chinese medicine composition 100g adds ethanol, makes alcohol content reach 65%, uses hydroxide
Sodium regulation pH to 6.8, stands 36 hours, filters, and adds ethanol, make alcohol content reach in filtrate
75%, stand 24 hours, filter, by filtrate recycling ethanol to without alcohol taste, heat micro-boiling 15 minutes,
Stirring evenly, add water to 1000ml, stir evenly, filter, embedding, (every ml contains 0.333g to obtain oral liquid
Crude drug).
Embodiment 12: cookies
1, composition: Fructus Alpiniae Oxyphyllae 50g, Poria 120g, Rhizoma Polygonati 150g, Fructus Lycii 60g, Radix Angelicae Sinensis
120g, Fructus Jujubae 180g, Folium Mori 80g, Semen Sesami Nigrum 300g, Semen Coicis 200g (add up to 1260g).
2, preparation method: the Chinese medicine in addition to Semen Sesami Nigrum and Semen Coicis is soaked 45 minutes,
The water surface is higher than raw material Chinese medicine, and amount of water is 8 times of total dose, and after boiling, little fire boiling state, maintains liquid level
Higher than raw material Chinese medicine height, decoct two hours, cross leaching filtrate, add the water of total dose 6 times,
After boiling, little fire boiling state, maintains liquid level higher than raw material Chinese medicine height, decocts two hours, filter and merge
Filtrate；
Then Semen Sesami Nigrum 300g and Semen Coicis 200g is crushed to jointly 100 mesh, adds and merge filter
Liquid, adds 1000g Self-raising flour, butter 600g, Saccharum Sinensis Roxb. 500g, egg 250g, presses
Bakee according to cookies preparation technology and form.
Embodiment 13: cookies
1, composition: Fructus Alpiniae Oxyphyllae 40g, Poria 100g, Rhizoma Polygonati 120g, Fructus Lycii 80g, Radix Angelicae Sinensis
100g, Fructus Jujubae 150g, Folium Mori 70g, Semen Sesami Nigrum 250g, Semen Coicis 250g (add up to 1160g).
2, preparation method: the Chinese medicine in addition to Semen Sesami Nigrum, Semen Coicis and Poria 30g is added water logging
Steeping 45 minutes, the water surface is higher than raw material Chinese medicine, and amount of water is 8 times of total dose, little fire boiling state after boiling,
Maintain liquid level higher than raw material Chinese medicine height, decoct two hours, cross leaching filtrate, add total medicine
Measuring the water of 6 times, after boiling, little fire boiling state, maintains liquid level higher than raw material Chinese medicine height, decocts two hours,
Filter merging filtrate；
Then Poria 30g, Semen Sesami Nigrum 250g and Semen Coicis 250g are crushed to 100 mesh jointly, add
Enter merging filtrate, add 1500g Self-raising flour, butter 800g, Saccharum Sinensis Roxb. 600g, egg 200
G, bakees according to cookies preparation technology and forms.
Following experimental example, is that product of the present invention is carried out when clinic is tested.
Experimental example 1
By testing the following examination personnel of taking, result of the test is as follows:
1) Soviet Union XX, man, 79 years old, suffer from dissection of aorta Type B arteriosclerosis heavier, development is very fast,
CTA confirms, in blood vessel, calcification point is intensive.Take embodiment 1 decoction 1 year, then do CTA confirmation
Within this year, vascular condition is without deteriorating again, and conscious health is than the most relatively comfortable, and Type B interlayer is more stable.
2) Zhao XX, man, 65 years old, right hand end water bowl trembled width at about 1 centimeter, takes embodiment 1
After decoction one month, do not tremble, sometimes tremble its amplitude also only 0.5 centimeter.
3) week XX, man, 55 years old, double palmaris brevis positions colour of skin was mulberry, and blood circulation difference is not
Freely.Taking embodiment 2 decoction one month, the both hands palmaris brevis position colour of skin is normal skin tone, without mulberry.
4) Lee XX, man, 70 years old, the right hand write hand shaking, writes out its body of word and sees and tremble sample.Clothes are real
Execute example 1 decoction one month, the word not trembling font can be write out with normal speed.
5) discipline XX, man, 56 years old, the right hand stretched, and the back of the hand is upwards raise one's hand, automatic appearance
Tremble 2 millimeters, take embodiment 3 decoction one month, then stretch out one's hand with same attitude, lose and tremble.
6) Lee XX, female, 60 years old, blood stasis blood deficiency complexion committee was yellow, and void is not mended, malaise,
Take embodiment 1 decoction after three weeks conscious energy foot, complexion is obviously improved.
7) what XX, man, 65 years old, tired think of, conscious insobriety was clear, and hypomnesis is the brightest
Aobvious, within five days, front thing is all forgotten, and takes embodiment 4 decoction after two weeks, and conscious thinking is relatively flexible,
Ponder a problem the most hard, five days front things relatively clear can be recalled, do not remember.
8) Lu XX, female, 55 years old, to sleep very poor, one night only falls asleep 4 hours, and memory is very poor,
Taking embodiment 1 decoction one week, can fall asleep the most every night more than 6 hours, memory has clear improvement.
9) XX is opened, man, 56, male climacteric syndrome, vigorous without morning, take embodiment 1 decoction
20 days, occur that morning vigorous, takes 30 days, has every day vigorous in morning.
10) high XX, man, 78 years old, over 20 years, about Sublingual, two big blood vessels were atropurpureus,
Lower lip is mulberry, takes embodiment 1 decoction 30 days, and about Sublingual, two big blood vessels (are just becoming Lycoperdon polymorphum Vitt
Often color), lower lip becomes pink.
11) Lee XX, man, 75 years old, phlegm-damp type body constitution was more daily when going upstairs, and lower limb is felt and seemingly filled lead,
Breathing greatly then occur in upper three floors, take embodiment 1 decoction surrounding, conscious go upstairs unconsciously painstaking,
Also occur without and breathe greatly.
12) high XX, man, 73 years old, conscious QI and blood was not smooth, and heavy sensation of the body is weak, and walking often, step can only
Stepping 30 centimeters, take embodiment 1 decoction surrounding, conscious body strength is strong, and often step of walking can step 60
Centimetre.
13) king XX, female, 40 years old, flu often occurs, immunity is relatively low, and often sense is in fatigue
State.Taking embodiment 1 decoction surrounding, do not occur flu over the past half year, conscious the most tired, energy is relatively
The most also foot.
14) king XX, man, 68 years old, prostatic hyperplasia pSA mark was much larger than 10, and urine 3-4 is played in every place
Secondary, to sleep poor, panesthesia's prostate position, in irriate state, takes embodiment 1 decoction after three weeks, continues
Continuous clothes, the most only get up and urinate once, and prostate irriate is the most inconspicuous.
Experimental example 2
With certain the most dry office dining room in the product news conference of Yi Gong hotel, Beijing, through 30 participants
Scholar and 60 veteran cadres take embodiment 5 health preserving wine, all feel not top, non-dry throat, blurt out
Along larynx, be in a cheerful frame of mind, make light of one's life by commiting suicide strong, energy is sufficient, without any side effects.
The merits such as integration of edible and medicinal herbs Chinese medicine composition of the present invention has arteriosclerosis, inhibition thrombosis
Effect.Its medicated wine then can potentiation further.Human body takes in ethanol in right amount can increase blood high-density
Lipoprotein, reduces low density lipoprotein, LDL.Low density lipoprotein, LDL is gallbladder in atheromatous plaque
The main provider of sterin.High density lipoprotein is smooth with low density lipoprotein, LDL competition blood vessel wall
Receptor on myocyte's serous coat, thus suppress vascular smooth muscle cell community and accumulation low-density
Lipoprotein, and then the formation of prevention of arterial atherosclerotic plaque.Wine is as the carrier of medicine, meeting
Improve the bioavailability of this Chinese medicine composition further.
Experimental example 3
Medicinal and edible Chinese medicine compositions of the present invention (combines with embodiment 1 Six-element medicinal and edible Chinese medicine
Thing) through modern Chinese medicine quantizing resonance instrument, (QRS quantum resonance spectrometer Hebei is received hundred river science and technology and is opened
Send out company limited) measure, as follows to 29 tonification data of human body, without any side effects, health preserving
Disease prevention index is ideal.
Human body generally normal value decision method:
Subhealth state (0 to+8), healthy normal value (+9 to+21), morbid state (0 to-21).
Result shows, QRS quantum detection goes out the health-preserving and disease-preventing rehabilitation of Chinese medicine composition of the present invention and refers to
Mark the most outstanding.Be improved particularly that immunologic function, the kidney invigorating, alleviation be extremely tired, inhibition thrombosis,
The function improving the aspect such as blood circulation, arteriosclerosis is the most notable.And have estimable
The good function improving memory；Human experimentation, effect curve and quantum detection characteristic coincide or
Close.
Take medicinal and edible Chinese medicine compositions of the present invention (being used for supplementing above quantal data) can help
Help patient to change to subhealth state, the quantal data of sub-healty adults can be made to become the quantum of Healthy People
Data, can make the quantal data of Healthy People become the quantal data of more Healthy People.Therefore reach foster
Life, prevention and the effect of rehabilitation.
In sum and clinical experiment confirm, the Chinese medicine composition of the present invention can be used for preventing and treating kidney yin
Void, insufficiency of kidney-YANG, kidney insufficiency, the hepatic and renal YIN deficiency, deficiency of spleen-YANG and kidneyYANG, deficiency of heart-yin, deficiency of heart-YANG,
Depression of liver-QI, disarmony between the heart and kidney etc. nine is demonstrate,proved.Have and improve memory, arteriosclerosis, suppression blood
Bolt formed, improve immunity, improve prostate gland symptoms, resisting fatigue, improvement sleep, blood fat reducing,
Blood sugar lowering, and the aspect effect such as antioxidation, anticancer, beauty treatment, relieving constipation, fat-reducing.
Although, used general explanation, detailed description of the invention and test, to this
Bright make detailed description, but on the basis of the present invention, it can have been made some modifications or improvements,
This will be apparent to those skilled in the art.Therefore, without departing from present invention spirit
On the basis of these modifications or improvements, belong to the scope of protection of present invention.
Claims (10)
1. one kind is improved immunity, arteriosclerosis, inhibition thrombosis, improves memory
Chinese medicine composition, it is characterised in that the Chinese medicine that described Chinese medicine composition comprises following weight portion is former
Material: Fructus Alpiniae Oxyphyllae 3-6 part, Poria 9-15 part, Rhizoma Polygonati 10-30 part, Fructus Lycii 5-10 part.
Chinese medicine composition the most according to claim 1, it is characterised in that described Chinese drug-treated group
Compound comprises the raw material of Chinese medicine of following weight portion: Fructus Alpiniae Oxyphyllae 4-6 part, Poria 12-15 part, Rhizoma Polygonati
20-30 part, Fructus Lycii 5-10 part.
Chinese medicine composition the most according to claim 1 and 2, it is characterised in that also include 5-9
Part Folium Mori.
4. according to the Chinese medicine composition described in claim 1-3 any one, it is characterised in that also
Including 10-30 part Fructus Jujubae.
5. according to the Chinese medicine composition described in claim 1-4 any one, it is characterised in that also
Including 5-15 part Radix Angelicae Sinensis.
6. according to the Chinese medicine composition described in claim 1-5 any one, it is characterised in that also
Including 10-30 part Semen Sesami Nigrum, 9-30 part Semen Coicis.
7. containing the health preserving wine of Chinese medicine composition described in claim 1-5 any one, its feature exists
In, use following steps to make: to weigh each Chinese medicine ingredients, medicinal water in then inciting somebody to action according to proportioning
Soaking 30-60 minute, amount of water is 5-6 times of Chinese medicine gross weight, then boils, little fire boiling after boiling
State, decocts 1-2 hour, crosses leaching filtrate, adds the water of Chinese medicine gross weight 5-6 times, decocts 1
Hour, filter, merge twice filtrate, be concentrated into be equivalent to crude drug weight 1-2 times, in obtaining
Drug composition decoction, then Chinese medicine composition decoction is blent with wine, Chinese medicine composition decoction with should
The volume ratio of wine is 1:(1-5), health preserving wine.
8. containing the preparation of Chinese medicine composition described in any one of claim 1-6, by this Chinese medicine composition
Separately made or be made up of this Chinese medicine composition and pharmaceutically acceptable carrier.
9. health preserving wine described in Chinese medicine composition, claim 7 described in any one of claim 1-6,
Preparation described in claim 8 is in preparation treatment or preventing and treating body subhealthy status disease product
Application.
Application the most according to claim 9, it is characterised in that described application is for improving note
Recall power, arteriosclerosis, inhibition thrombosis, raising immunity, improve prostate gland symptoms,
Resisting fatigue, improve sleep, blood fat reducing, blood sugar lowering, antioxidation, anticancer, improve looks, relieving constipation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610300845.1A CN105833148A (en) | 2016-05-09 | 2016-05-09 | Traditional Chinese medicine composition with effects of improving memory, resisting arteriosclerosis, inhibiting thrombosis and improving immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610300845.1A CN105833148A (en) | 2016-05-09 | 2016-05-09 | Traditional Chinese medicine composition with effects of improving memory, resisting arteriosclerosis, inhibiting thrombosis and improving immunity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105833148A true CN105833148A (en) | 2016-08-10 |
Family
ID=56591210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610300845.1A Pending CN105833148A (en) | 2016-05-09 | 2016-05-09 | Traditional Chinese medicine composition with effects of improving memory, resisting arteriosclerosis, inhibiting thrombosis and improving immunity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105833148A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106974285A (en) * | 2017-03-31 | 2017-07-25 | 江苏康缘药业股份有限公司 | A kind of Chinese medicine composition and its application |
| CN106995772A (en) * | 2017-05-18 | 2017-08-01 | 江苏洋河酒厂股份有限公司 | A kind of health liquor of strengthen immunity |
| CN109757582A (en) * | 2018-12-29 | 2019-05-17 | 江苏鹤莱科技有限公司 | Improve the nutritional food formula of benign prostate hyperplasia shape |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1240591A (en) * | 1998-06-30 | 2000-01-12 | 肖树恩 | Diabetic sugar |
| CN1565249A (en) * | 2003-07-05 | 2005-01-19 | 张锐 | Chinese medicinal herb nutritious seasoning for cooking |
| CN103316144A (en) * | 2013-07-08 | 2013-09-25 | 宋述伋 | Chinese medicine composition capable of invigorating qi and blood, nourishing yin and yang, improving immunity, resisting to fatigue and inhibiting thrombogenesis |
-
2016
- 2016-05-09 CN CN201610300845.1A patent/CN105833148A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1240591A (en) * | 1998-06-30 | 2000-01-12 | 肖树恩 | Diabetic sugar |
| CN1565249A (en) * | 2003-07-05 | 2005-01-19 | 张锐 | Chinese medicinal herb nutritious seasoning for cooking |
| CN103316144A (en) * | 2013-07-08 | 2013-09-25 | 宋述伋 | Chinese medicine composition capable of invigorating qi and blood, nourishing yin and yang, improving immunity, resisting to fatigue and inhibiting thrombogenesis |
Non-Patent Citations (1)
| Title |
|---|
| 杨力: "《杨力解读中华养生智慧》", 31 January 2012, 科学技术文献出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106974285A (en) * | 2017-03-31 | 2017-07-25 | 江苏康缘药业股份有限公司 | A kind of Chinese medicine composition and its application |
| CN106974285B (en) * | 2017-03-31 | 2020-12-08 | 江苏康缘药业股份有限公司 | Traditional Chinese medicine composition and application thereof |
| CN106995772A (en) * | 2017-05-18 | 2017-08-01 | 江苏洋河酒厂股份有限公司 | A kind of health liquor of strengthen immunity |
| CN109757582A (en) * | 2018-12-29 | 2019-05-17 | 江苏鹤莱科技有限公司 | Improve the nutritional food formula of benign prostate hyperplasia shape |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102836379B (en) | Traditional Chinese medicine compound preparation for reducing lipid and dispelling effects of alcohol as well as preparation method and application of same | |
| CN103520621B (en) | A kind of Chinese medicine composition for the treatment of senile cataract and preparation method thereof | |
| CN103860969A (en) | Traditional Chinese medicine for increasing weight | |
| CN101002906A (en) | Compounding traditional Chinese medicine, and its use | |
| CN103405728B (en) | A kind of Chinese medicine composition for the treatment of climacteric syndrome and preparation method thereof | |
| CN105833148A (en) | Traditional Chinese medicine composition with effects of improving memory, resisting arteriosclerosis, inhibiting thrombosis and improving immunity | |
| CN105232911A (en) | Traditional Chinese medicine composition | |
| CN101468150B (en) | Chinese medicinal composition for tonifying kidney and moistening hair, preparation and method for preparing the same | |
| CN103989970B (en) | A kind of Chinese medicine composition treating hypertension | |
| CN103977206B (en) | Improve Chinese medicine preparation and the production method thereof of gastrointestinal disturbances systemic-function | |
| CN102940730A (en) | Traditional Chinese medicine for treating hypertension | |
| CN106177477A (en) | A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering | |
| CN101099775B (en) | Cardiac and cerebral vascular disease treating medicine | |
| CN103316144B (en) | Chinese medicine composition capable of invigorating qi and blood, nourishing yin and yang, improving immunity, resisting to fatigue and inhibiting thrombogenesis | |
| CN104740054B (en) | A kind of pharmaceutical composition for preventing and treating myocardial ischemia and its production and use | |
| CN103463456A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| CN105560911B (en) | A kind of Chinese medicine and preparation method thereof for treating hypertension | |
| CN104432386A (en) | Loranthus parasiticus oral liquid for preventing soreness and weakness of waist and knees and weak muscles and bones and preparation method thereof | |
| CN104906399A (en) | Traditional Chinese medicine pills for treating heart disease and preparation method of traditional Chinese medicine pills | |
| CN104524479A (en) | Traditional Chinese medicine composition for treating premenstrual syndrome and preparation method of traditional Chinese medicine composition | |
| CN109718305A (en) | Improve energy and blood of human body function and improves the Chinese medicine composition that resist oxygen lack delays senescence | |
| CN103495101B (en) | Traditional Chinese medicine composition for treating stomachache | |
| CN106110089A (en) | A kind of Chinese medicine composition treating anxiety, insomnia and preparation method thereof | |
| CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease | |
| CN100574796C (en) | Treat cardiopathic medicine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160810 |